Previous exposure to Chlamydia pneumoniae, Helicobacter pylori and other infections in Canadian patients with ischemic heart disease

Canadian Journal of Cardiology

Volumn 17, Issue 3, 2001, Pages 270-276

  Smieja, M ^a   Cronin, L ^a   Levine, M ^a   Goldsmith, C H ^a   Yusuf, S ^a   Mahony, J B ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Coronary disease; Infection

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G;

ADENOVIRUS; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CANADA; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; FEMALE; HEART INFARCTION; HELICOBACTER PYLORI; HEPATITIS A VIRUS; HUMAN; INFECTION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SEROLOGY; SEROPREVALENCE; STATISTICAL ANALYSIS; UNSTABLE ANGINA PECTORIS; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ANGIOGRAPHY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ONTARIO; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035050306     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Atherosclerosis - An inflammatory disease
2. The pathogenesis of atherosclerosis - An update
3. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
4. Plasma fibrinogen and incident hypertension in the Atherosclerosis Risk in Communities (ARIC) Study
5. Infectious agents that play a role in atherosclerosis and vasculopathies. What are they? What do we do about them?
6. Chronic infections and coronary heart disease: Is there a link?
7. Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: Meta-analyses of prospective studies
8. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues
9. Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients
10. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
11. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease
12. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms
13. Rabbit model for Chlamydia pneumoniae infection
14. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
15. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
16. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
17. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study.ROXIS Pilot Study Group
18. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
19. WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics
20. Anti-inflammatory activity of macrolide antibiotics
21. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not
22. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women
23. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators
24. Detection of cytomegalovirus in paraffin-embedded postmortem coronary artery specimens of heart transplant recipients by the polymerase chain reaction: Implications of cytomegalovirus association with graft atherosclerosis
25. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy
26. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall
27. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction
28. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR
29. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association
30. Chlamydia, smoking, and heart disease
31. Serological response to Chlamydia pneumoniae infection
32. Chlamydia pneumoniae (TWAR)
33. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction
34. Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and meta-analysis
35. Chlamydia pneumoniae infection and mortality from ischaemic heart disease: Large prospective study
36. Commentary: Adjustment for potential confounders may have been taken too far
37. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients